Punchbowl
PUNCHBOWL NEWS is a news community that operates on a membership basis, created by journalists and bestselling authors JAKE SHERMAN and ANNA PALMER, with the collaboration of seasoned Capitol Hill reporter JOHN BRESNAHAN. The name Punchbowl comes from the Secret Service's nickname for the Capitol. Our guiding principles are Power, People, and Politics. We are dedicated to covering the individuals in Washington who drive decision-making and the news that influences political landscapes. Through Punchbowl events, you can gain deeper insights into the happenings in Washington and its leadership. Become a member of our community today.
Outlet metrics
Global
#123316
United States
#33875
Law and Government/Government
#647
Articles
-
1 week ago |
punchbowl.news | Brendan Pedersen
Listen to our daily podcast, where we break down the top stories of the day in Washington, and how headlines across the globe will impact governing in D.C.
-
2 weeks ago |
punchbowl.news | Jake Sherman
Listen to our daily podcast, where we break down the top stories of the day in Washington, and how headlines across the globe will impact governing in D.C.
-
3 weeks ago |
punchbowl.news | Jake Sherman
For too long, Big Pharma put Americans last – keeping drug prices high in the U.S. and lower in other wealthy countries. While they protect their profits, Americans struggle. Why are we getting a bad deal? Learn more.
-
4 weeks ago |
punchbowl.news | Jake Sherman
For too long, Big Pharma put Americans last – keeping drug prices high in the U.S. and lower in other wealthy countries. While they protect their profits, Americans struggle. Why are we getting a bad deal? Learn more.
-
1 month ago |
punchbowl.news | Jake Sherman
For too long, Big Pharma put Americans last – keeping drug prices high in the U.S. and lower in other wealthy countries. While they protect their profits, Americans struggle. Why are we getting a bad deal? Learn more.
Contact details
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →